• Publications
  • Influence
The role of radiation therapy in the treatment of astrocytomas
One hundred forty‐seven patients with astrocytoma were treated between 1942 and 1967. There were 25 postoperative deaths. The 14 patients in whom the tumor was thought to have been completely removedExpand
  • 205
  • 5
Radiation therapy in the treatment of partially resected meningiomas.
To address the question of whether radiation therapy is beneficial in the management of partially resected meningiomas, we reviewed the records of all patients admitted to the University ofExpand
  • 304
  • 5
THERAPEUTIC CONSIDERATIONS IN TUMORS AFFECTING THE CENTRAL NERVOUS SYSTEM: EPENDYMOMAS.
Ependymomas constitute a small but well defined group of the gliomas. The facts that all reported series are relatively small and that systems of classification differ probably account for theExpand
  • 74
  • 4
Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors.
Thirty-eight patients with symptomatic recurrent primary or metastatic brain tumors were treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at an initial dose of 120-130 mg/m2 withExpand
  • 66
  • 4
Radiation therapy of meningiomas.
  • 246
  • 1
Efficacy of irradiation for incompletely excised acoustic neurilemomas.
The records of 124 patients treated for acoustic neurilemoma at the University of California, San Francisco, from 1945 through 1983 were reviewed. Patients were classified by the extent of surgicalExpand
  • 90
  • 1
Single-agent chemotherapy of brain tumors. A five-year review.
Identification of effective single chemotherapeutic agents for brain tumors must precede the rational use of multiple drug combinations. In phase 2 trials beginning in 1968, 158 patients withExpand
  • 102
  • 1
Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors
Forty‐eight patients with primary or metastatic malignant tumors of the central nervous system (CNS) were treated with combination chemotherapy, consisting of procarbazine (100 mg/m2 × 14 days), CCNUExpand
  • 79
  • 1
...
1
2
3
4
5
...